177 related articles for article (PubMed ID: 33171418)
21. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
[TBL] [Abstract][Full Text] [Related]
22. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study.
Syrjänen K; Naud P; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Matos J; Gontijo R; Sarian L; Braganca J; Arlindo FC; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S
Anticancer Res; 2005; 25(5):3469-80. PubMed ID: 16101165
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
24. A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers.
Wentzensen N; Walker J; Smith K; Gold MA; Zuna R; Massad LS; Liu A; Silver MI; Dunn ST; Schiffman M
Am J Obstet Gynecol; 2018 Jun; 218(6):604.e1-604.e8. PubMed ID: 29462629
[TBL] [Abstract][Full Text] [Related]
25. HPV testing with cytology triage for cervical cancer screening in routine practice.
Louvanto K; Chevarie-Davis M; Ramanakumar AV; Franco EL; Ferenczy A
Am J Obstet Gynecol; 2014 May; 210(5):474.e1-7. PubMed ID: 24373948
[TBL] [Abstract][Full Text] [Related]
26. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
[TBL] [Abstract][Full Text] [Related]
27. Cervical screening: management of patients referred for colposcopy with smear abnormalities less severe than dyskaryosis.
Usman F; Hammond R
Cytopathology; 1998 Apr; 9(2):100-6. PubMed ID: 9577736
[TBL] [Abstract][Full Text] [Related]
28. Role of the HPV DNA test in follow-up of treated cervical intraepithelial neoplasia in Bangladesh.
Nessa A; Rashid MH; Jahan M; Ferdous NE; Nahar PA; Chowdhury A
Asian Pac J Cancer Prev; 2014; 15(19):8063-7. PubMed ID: 25338985
[TBL] [Abstract][Full Text] [Related]
29. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.
Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N
Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849
[TBL] [Abstract][Full Text] [Related]
30. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.
Fontham ETH; Wolf AMD; Church TR; Etzioni R; Flowers CR; Herzig A; Guerra CE; Oeffinger KC; Shih YT; Walter LC; Kim JJ; Andrews KS; DeSantis CE; Fedewa SA; Manassaram-Baptiste D; Saslow D; Wender RC; Smith RA
CA Cancer J Clin; 2020 Sep; 70(5):321-346. PubMed ID: 32729638
[TBL] [Abstract][Full Text] [Related]
32. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
[TBL] [Abstract][Full Text] [Related]
33. HPV testing is an efficient management choice for women with inadequate liquid-based cytology in cervical cancer screening.
Giorgi Rossi P; Carozzi F; Collina G; Confortini M; Dalla Palma P; De Lillo M; Del Mistro A; Ghiringhello B; Gillio-Tos A; Maioli P; Pellegrini A; Schiboni ML; Segnan N; Zaffina LM; Zorzi M; Ronco G;
Am J Clin Pathol; 2012 Jul; 138(1):65-71. PubMed ID: 22706859
[TBL] [Abstract][Full Text] [Related]
34. hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi).
Carozzi FM; Iossa A; Scalisi A; Sideri M; Andersson KL; Confortini M; Del Mistro A; Maina G; Ronco G; Raggi P; Schiboni ML; Zappa M; Giorgi Rossi P
Epidemiol Prev; 2015; 39(3 Suppl 1):84-90. PubMed ID: 26405780
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.
Monsonego J; Pintos J; Semaille C; Beumont M; Dachez R; Zerat L; Bianchi A; Franco E
Int J Gynecol Cancer; 2006; 16(2):591-8. PubMed ID: 16681731
[TBL] [Abstract][Full Text] [Related]
36. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study.
Nobbenhuis MA; Walboomers JM; Helmerhorst TJ; Rozendaal L; Remmink AJ; Risse EK; van der Linden HC; Voorhorst FJ; Kenemans P; Meijer CJ
Lancet; 1999 Jul; 354(9172):20-5. PubMed ID: 10406360
[TBL] [Abstract][Full Text] [Related]
37. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y
Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065
[TBL] [Abstract][Full Text] [Related]
38. Cervical Colposcopy: Indications and Risk Assessment.
Burness JV; Schroeder JM; Warren JB
Am Fam Physician; 2020 Jul; 102(1):39-48. PubMed ID: 32603071
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
[No Abstract] [Full Text] [Related]
40. Cervical Cancer Screening with HPV Testing: Updates on the Recommendation.
Carvalho CF; Teixeira JC; Bragança JF; Derchain S; Zeferino LC; Vale DB
Rev Bras Ginecol Obstet; 2022 Mar; 44(3):264-271. PubMed ID: 35170010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]